Takeaki Takeuchi1, Mutsuhiro Nakao, Yuko Kachi, Eiji Yano. 1. Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan; Division of Psychosomatic Medicine, Teikyo University Hospital, Tokyo, Japan.
Abstract
AIM: It has been controversial whether metabolic syndrome (MetS) is associated with depression. We aimed to clarify the correlation between MetS and depression, considering atypical features of depression. METHODS: Participants were 1011 Japanese men aged 20-59 years. MetS was diagnosed according to criteria set by the International Diabetes Federation. Clinical interviews for major depressive disorder (MDD) employed the DSM-IV; MDD was classified into atypical and non-atypical types. The prevalence of MetS was compared between the groups with no MDD, atypical depression, and non-atypical depression via trend analyses. Multiple logistic regression analyses examined the association of MetS with atypical depression and the features thereof. RESULTS: In total, 141 (14.0%) participants were diagnosed with MetS and 57 (5.6%) were diagnosed with MDD (14 had atypical and 43 had non-atypicalMDD). The prevalence of MetS was the highest in the group with atypical depression, followed by the non-atypical depression and no MDD groups, respectively, with a marginally significant trend (P = 0.07). The adjusted odds ratios of MetS associated with depression were 3.8 (95% confidence interval [CI] 1.1-13.2) for atypical depression and 1.6 (95% CI 0.7-3.6) for non-atypical depression. Among the five features of atypical depression, only hyperphagia was significantly related to MetS (odds ratio 2.7, 95% CI 1.8-4.1). CONCLUSION: There was a positive association between MetS and atypical depression, but not between MetS and non-atypical depression. Specifically, hyperphagia seems to be an important factor affecting the correlation between MetS and atypical depression.
AIM: It has been controversial whether metabolic syndrome (MetS) is associated with depression. We aimed to clarify the correlation between MetS and depression, considering atypical features of depression. METHODS:Participants were 1011 Japanese men aged 20-59 years. MetS was diagnosed according to criteria set by the International Diabetes Federation. Clinical interviews for major depressive disorder (MDD) employed the DSM-IV; MDD was classified into atypical and non-atypical types. The prevalence of MetS was compared between the groups with no MDD, atypical depression, and non-atypical depression via trend analyses. Multiple logistic regression analyses examined the association of MetS with atypical depression and the features thereof. RESULTS: In total, 141 (14.0%) participants were diagnosed with MetS and 57 (5.6%) were diagnosed with MDD (14 had atypical and 43 had non-atypicalMDD). The prevalence of MetS was the highest in the group with atypical depression, followed by the non-atypical depression and no MDD groups, respectively, with a marginally significant trend (P = 0.07). The adjusted odds ratios of MetS associated with depression were 3.8 (95% confidence interval [CI] 1.1-13.2) for atypical depression and 1.6 (95% CI 0.7-3.6) for non-atypical depression. Among the five features of atypical depression, only hyperphagia was significantly related to MetS (odds ratio 2.7, 95% CI 1.8-4.1). CONCLUSION: There was a positive association between MetS and atypical depression, but not between MetS and non-atypical depression. Specifically, hyperphagia seems to be an important factor affecting the correlation between MetS and atypical depression.
Authors: Manpreet K Singh; Sara M Leslie; Mary Melissa Packer; Yevgeniya V Zaiko; Owen R Phillips; Elizabeth F Weisman; Danielle M Wall; Booil Jo; Natalie Rasgon Journal: Horm Behav Date: 2018-04-23 Impact factor: 3.587
Authors: A M Lasserre; M-P F Strippoli; J Glaus; M Gholam-Rezaee; C L Vandeleur; E Castelao; P Marques-Vidal; G Waeber; P Vollenweider; M Preisig Journal: Mol Psychiatry Date: 2016-10-11 Impact factor: 15.992
Authors: Jannica S Selenius; Niko S Wasenius; Hannu Kautiainen; Minna Salonen; Mikaela von Bonsdorff; Johan G Eriksson Journal: BMJ Open Diabetes Res Care Date: 2020-10
Authors: Jörg Wiltink; Matthias Michal; Claus Jünger; Thomas Münzel; Philipp S Wild; Karl J Lackner; Maria Blettner; Norbert Pfeiffer; Elmar Brähler; Manfred E Beutel Journal: BMC Psychiatry Date: 2018-04-27 Impact factor: 3.630